U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214688) titled 'Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies' on Oct. 03.
Brief Summary: The Flu-TBI 800 trial is a prospective, single-arm, multicenter, interventional phase 2 study to evaluate whether fludarabine plus intermediate-dose total body irradiation (TBI 800 cGy) with post-transplant cyclophosphamide (PTCy) (experimental regimen) improves the 1-year survival of allogeneic stem cell transplant recipients.
Study Start Date: Oct. 15
Study Type: INTERVENTIONAL
Condition:
Allogeneic Stem Cell Transplant Recipient
Intervention:
DRUG: Fludarabine
Patients will receive...